BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Clinical trial NCT07193511 · RECRUITING

Trial details

NCT number: NCT07193511
Sponsor: Avenzo Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Cancer Locally Advanced Metastatic Solid Tumors Urothelial Cancer

Start date: 2025-10-02
Primary completion: 2030-03-01
Enrollment: 355

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.